Swiss All Share Index

Swiss All Share Index handeln
19.785,85 PKT -95,35 PKT -0,48 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
14.09.20 Roche overweight JP Morgan Chase & Co.
14.09.20 Zurich Insurance overweight JP Morgan Chase & Co.
11.09.20 Holcim buy UBS AG
10.09.20 Novartis buy UBS AG
09.09.20 Swiss Re buy UBS AG
09.09.20 Zurich Insurance buy UBS AG
08.09.20 Swiss Re Outperform RBC Capital Markets
08.09.20 Zurich Insurance Sector Perform RBC Capital Markets
08.09.20 Clariant Neutral Credit Suisse Group
08.09.20 Zurich Insurance overweight Barclays Capital
08.09.20 Swiss Re overweight Barclays Capital
07.09.20 Swiss Life Neutral JP Morgan Chase & Co.
07.09.20 Nestlé buy Kepler Cheuvreux
07.09.20 Givaudan buy UBS AG
07.09.20 Zurich Insurance overweight JP Morgan Chase & Co.
07.09.20 Swiss Re overweight JP Morgan Chase & Co.
07.09.20 ams-OSRAM Outperform Credit Suisse Group
04.09.20 UBS Neutral UBS AG
04.09.20 Givaudan add Baader Bank
04.09.20 UBS Sector Perform RBC Capital Markets
04.09.20 UBS Sector Perform RBC Capital Markets
04.09.20 Roche overweight JP Morgan Chase & Co.
03.09.20 ams-OSRAM overweight JP Morgan Chase & Co.
02.09.20 Roche buy UBS AG
02.09.20 Roche overweight JP Morgan Chase & Co.
02.09.20 Holcim overweight JP Morgan Chase & Co.
02.09.20 UBS buy Goldman Sachs Group Inc.
02.09.20 UBS buy Goldman Sachs Group Inc.
01.09.20 Givaudan buy UBS AG
01.09.20 Novartis overweight Morgan Stanley
01.09.20 Nestlé overweight JP Morgan Chase & Co.
01.09.20 Nestlé Hold Deutsche Bank AG
01.09.20 UBS Neutral UBS AG
01.09.20 Nestlé Underperform RBC Capital Markets
28.08.20 Givaudan Neutral JP Morgan Chase & Co.
27.08.20 Givaudan Neutral JP Morgan Chase & Co.
27.08.20 Givaudan add Baader Bank
27.08.20 Zurich Insurance buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
26.08.20 UBS Neutral UBS AG
26.08.20 Novartis Conviction Buy List Goldman Sachs Group Inc.